Related Experiment Video
Updated: Jun 3, 2026

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
Published on: May 28, 2014
DNA reactivity profile of trans-platinum planar amine derivatives
Caterina Musetti1, Alexey A Nazarov, Nicholas P Farrell
1Department of Pharmaceutical Sciences, University of Padova, v. Marzolo 5, Padova, Italy.
Abstract:
New trans-platinum planar amines (TPAs) represent a family of platinum-based drugs with cytotoxicity equivalent to that of cisplatin, but with negligible cross-resistance. According to the substitution pattern around the metal center, distinct DNA adducts can be formed which yield various levels of cytotoxicity in cell lines. We compared the effects of leaving groups (Cl(-) versus formate or acetate) and amines (NH(3) versus aromatic heterocyclic planar systems) on the efficiency, kinetics, and mode of DNA platination. We show that the substitution of just a single amino group on the transplatin nucleus is optimal, with major effects on the kinetics of metal complex conversion into the reactive aquo species. Additionally, by monitoring TPA reactivity toward variable DNA structures, a lack of preference for double-stranded DNA in over single-stranded or G-quadruplex DNA was observed which is possibly related to steric effects of the planar amine groups. These properties can lead to a unique distribution of platination sites by TPA relative to the lead compound cisplatin, which may help to explain the unique cytotoxic profile of TPAs.
Insights
New platinum-based drugs, trans-platinum planar amines (TPAs), show potent cytotoxicity with minimal resistance. Their unique DNA binding properties differ from cisplatin, potentially explaining their distinct therapeutic profiles.
Area of Science:
- Medicinal Chemistry
- Molecular Biology
- Cancer Therapeutics
Background:
- Cisplatin is a widely used platinum-based chemotherapy drug.
- Drug resistance and toxicity limit cisplatin's efficacy.
- Novel platinum-based drugs are needed to overcome these limitations.
Purpose of the Study:
- To investigate the structure-activity relationships of trans-platinum planar amines (TPAs).
- To compare the DNA platination efficiency, kinetics, and adduct formation of TPAs with cisplatin.
- To understand how TPA properties influence their cytotoxic effects.
Main Methods:
- Synthesis and characterization of various TPAs with different leaving groups and amine substituents.
- In vitro studies to assess cytotoxicity against cancer cell lines.
- DNA binding assays to monitor platination kinetics and adduct formation on different DNA structures (double-stranded, single-stranded, G-quadruplex).
Main Results:
- TPAs exhibit cytotoxicity comparable to cisplatin but with negligible cross-resistance.
- Substitution of a single amino group on the transplatin nucleus optimizes TPA activity.
- TPAs show a lack of preference for double-stranded DNA, binding instead to single-stranded and G-quadruplex DNA, potentially due to steric effects.
- This altered DNA binding leads to a unique distribution of platination sites compared to cisplatin.
Conclusions:
- TPAs represent a promising class of platinum-based anticancer agents with a distinct mechanism of action.
- Their unique DNA binding properties and reduced cross-resistance offer potential advantages over cisplatin.
- Further research into TPAs could lead to novel cancer treatment strategies.
More Related Videos
10:05Genome-wide Mapping of Drug-DNA Interactions in Cells with COSMIC (Crosslinking of Small Molecules to Isolate Chromatin)
Published on: January 20, 2016
12:08Catalytic Reactions at Amine-Stabilized and Ligand-Free Platinum Nanoparticles Supported on Titania During Hydrogenation of Alkenes and Aldehydes
Published on: June 24, 2022
Related Concept Videos
Physical Properties of Amines
Basicity of Aromatic Amines
2° Amines to N-Nitrosamines: Reaction with NaNO2
Structure of Amines
Basicity of Heterocyclic Aromatic Amines
NMR Spectroscopy Of Amines